Cambridge Technologies uses industry-leading diagnostic technology and manufacturing practices to bring autogenous vaccings to innovative beterinarians and dairymen and women.

Our goals are to Identify emerging pathogens, prevent diseases they may cause. and reduce
dependence on antibiotics. We utilize the latest diagnostic technology to identify and characterize pathogens. then build vaccine containing the antigens that will best combat the specific disease threats.
In addition to our custom vaccines, our NEW conditionally-licensed baculovirus wart vaccine is the only one on the market with consistent availability backed by proven science. It contains BPV Type 1, the most common type or bovine papillomavirus.